78 results
8-K/A
EX-99.1
GMDAQ
Gamida Cell Ltd
5 Apr 24
Other Events
5:16pm
STATEMENTS OF OPERATIONS
U.S. dollars in thousands (except share and per share data)
Year ended
December 31,
Research and development expenses, net … of its efforts toward research and development activities. In the course of such activities, the Company has sustained operating losses and expects
8-K/A
EX-99.1
GMDAQ
Gamida Cell Ltd
28 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:47pm
research and development expenses. Research and development in the field requires a high level of scientific know-how, advanced technologies and extensive … .
Translated from the Hebrew
Legaltrans
After years of research, development and clinical trials, the Company received regulatory approval from
8-K
EX-99.1
b3qvk1t
27 Mar 24
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
7:30am
8-K
EX-99.1
4owirhg
14 Nov 23
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
12:00am
8-K
EX-99.1
9dc 796ss3d08xr
14 Aug 23
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
7:30am
8-K
EX-99.1
0itu5zi d816
15 May 23
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
12:00am
8-K
EX-99.1
7pq1p828kt
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-10.1
6rsoe9rjf m16rgpv
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-99.1
e0s1hxcy4e
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
8-K
EX-10.1
9do8fww99gj7yd7g
19 Sep 22
Departure of Directors or Certain Officers
7:06am